Form 13-F position report

IKANG HEALTHCARE GROUP INC SPO

Reported by GLG Partners LP

KANG CUSIP 45174L108 Manager CIK 0001289643

Reported 603,000 shares, up 293,249 (94.7%) from the prior quarter.

Reported value 63.3%; share count 94.7% vs. the prior quarter.

Added
% of reported 13F value 0.33% This manager · Q2 2016
Shares 603,000 Quarter-end amount reported
Reported value $11,059,000 Fair value at quarter end
Consecutive quarters held 2 Through Q2 2016

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2015-06-30 504000
2015-09-30 0
2016-03-31 6771000
2016-06-30 11059000
2016-09-30 19849000
2016-12-31 26273000
2017-03-31 22185000
2017-06-30 21529000
2017-09-30 24603000
2017-12-31 29821000

Quarterly position history

How this manager's reported quarter-end position changed over time.

10 quarters
Quarterly reported position history for IKANG HEALTHCARE GROUP INC SPO held by GLG Partners LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2017 Added 1,887,410 +62,233 (3.4%) 1.39% $29,821,000 2018-02-14
Q3 2017 Added 1,825,177 +70,607 (4.0%) 1.3% $24,603,000 2017-11-14
Q2 2017 Added 1,754,570 +235,056 (15.5%) 1.19% $21,529,000 2017-08-14
Q1 2017 Added 1,519,514 +3,471 (0.2%) 1.04% $22,185,000 2017-05-15
Q4 2016 Added 1,516,043 +418,480 (38.1%) 1.05% $26,273,000 2017-02-14
Q3 2016 Added 1,097,563 +494,563 (82.0%) 0.61% $19,849,000 2016-11-14
Q2 2016 Added 603,000 +293,249 (94.7%) 0.33% $11,059,000 2016-08-16
Q1 2016 New 309,751 +309,751 (0.0%) 0.19% $6,771,000 2016-05-16
Q3 2015 Reduced 0 -26,039 (-100.0%) 0 $0 2015-11-16
Q2 2015 New 26,039 +26,039 (0.0%) 0.01% $504,000 2015-08-14

Who else reported the position

67 managers reported IKANG HEALTHCARE GROUP INC SPO for Q2 2016.

Managers reporting IKANG HEALTHCARE GROUP INC SPO in Q2 2016.
Manager Activity Shares Change % of reported 13F Reported value Tenure
The Goldman Sachs Group Inc Reduced 4,386,290 -907 0.03% $80,445,000 8 qtrs
Fosun International Ltd Added 2,423,972 +242,519 4.3% $44,488,000 5 qtrs
All-Stars Investment Ltd Reduced 1,046,259 -97,120 16.23% $19,189,000 4 qtrs
QVT Financial LP Reduced 892,170 -73,547 1.13% $16,362,000 2 qtrs
FIRST MANHATTAN CO Reduced 656,244 -209,825 0.07% $12,035,000 3 qtrs
GLG Partners LP This report Added 603,000 +293,249 0.33% $11,059,000 2 qtrs
OXFORD ASSET MANAGEMENT LLP Unchanged 600,000 0 0.36% $11,004,000 2 qtrs
FIL Ltd Unchanged 409,183 0 0.02% $7,504,000 8 qtrs
Citigroup Inc Reduced 359,631 -42,387 < 0.01% $6,596,000 5 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 343,200 -156,100 0.01% $6,294,000 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2016
Filed
August 16, 2016
Filing type
13F-HR
Position type
SPONSORED ADR

Voting authority reported

Sole
603,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.